153 related articles for article (PubMed ID: 81636)
1. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection.
Waldman RH; Ganguly R
Ann N Y Acad Sci; 1977 Mar; 284():153-60. PubMed ID: 81636
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis.
Galbraith GM; Thiers BH; Jensen J; Hoehler F
J Am Acad Dermatol; 1987 May; 16(5 Pt 1):977-83. PubMed ID: 2438319
[TBL] [Abstract][Full Text] [Related]
3. Effect of inosiplex (Isoprinosine) on induced human influenza A infection.
Khakoo RA; Watson GW; Waldman RH; Ganguly R
J Antimicrob Chemother; 1981 Apr; 7(4):389-97. PubMed ID: 6166605
[No Abstract] [Full Text] [Related]
4. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study.
Georgala S; Katoulis AC; Befon A; Georgala K; Stavropoulos PG
Acta Derm Venereol; 2006; 86(5):422-4. PubMed ID: 16955187
[TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin and inosiplex: a review of their present status in viral diseases.
Chang TW; Heel RC
Drugs; 1981 Aug; 22(2):111-28. PubMed ID: 6167418
[TBL] [Abstract][Full Text] [Related]
7. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency.
Galbraith GM; Thiers BH; Fudenberg HH
J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):224-30. PubMed ID: 6207216
[TBL] [Abstract][Full Text] [Related]
8. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study.
Feldman S; Hayes FA; Chaudhary S; Ossi M
Antimicrob Agents Chemother; 1978 Sep; 14(3):495-7. PubMed ID: 81655
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection.
Bradshaw LJ; Sumner HL
Ann N Y Acad Sci; 1977 Mar; 284():190-6. PubMed ID: 81637
[No Abstract] [Full Text] [Related]
10. Failure of oral inosiplex treatment of recurrent herpes simplex virus infections.
Kalimo KO; Joronen IA; Havu VK
Arch Dermatol; 1983 Jun; 119(6):463-7. PubMed ID: 6190441
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of isoprinosine in experimental human rhinovirus infection.
Pachuta DM; Togo Y; Hornick RB; Schwartz AR; Tominaga S
Antimicrob Agents Chemother; 1974 Apr; 5(4):403-8. PubMed ID: 15825396
[TBL] [Abstract][Full Text] [Related]
12. Inosiplex in recurrent herpes simplex infection.
Abeles JH
Lancet; 1982 Oct; 2(8304):926. PubMed ID: 6181365
[No Abstract] [Full Text] [Related]
13. Inosiplex in recurrent herpes simplex infections.
Galli M; Lazzarin A; Moroni M; Zanussi C
Lancet; 1982 Aug; 2(8293):331-2. PubMed ID: 6178916
[No Abstract] [Full Text] [Related]
14. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
DuRant RH; Dyken PR; Swift AV
J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
[TBL] [Abstract][Full Text] [Related]
15. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
Beran J; Šalapová E; Špajdel M;
BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
[TBL] [Abstract][Full Text] [Related]
17. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
Sperber SJ; Hendley JO; Hayden FG; Riker DK; Sorrentino JV; Gwaltney JM
Ann Intern Med; 1992 Jul; 117(1):37-41. PubMed ID: 1317694
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.
Ohnishi H; Kosuzume H; Inaba H; Okura M; Morita Y; Mochizuki H; Suzuki Y
Infect Immun; 1982 Oct; 38(1):243-50. PubMed ID: 6183209
[TBL] [Abstract][Full Text] [Related]
19. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
Haddad FS; Risk WS
Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
[TBL] [Abstract][Full Text] [Related]
20. Inosiplex in the treatment of subacute sclerosing panencephalitis.
Silverberg R; Brenner T; Abramsky O
Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
